EllenRx®Gastroenterology

Skyrizi denied by insurance? What insurers ask for and how to appeal

risankizumab-rzaa · Sources reviewed Nov 10, 2026 · Sources below

Used for
4 conditions (see above)
How it's given
3 IV infusions, then injection under the skin
Prior authorization usually required?
Varies by plan

What does my insurer usually ask for before approving Skyrizi?

  • Prescribed by or with a specialistPlans want a skin, joint, or gut specialist (based on your condition) to prescribe it or sign off on it.
  • Not taking another biologic for the same conditionPlans will not pay for this drug together with another similar advanced drug for the same condition.
  • Diagnosis of moderate to severe diseaseYour records should show your condition is active and at least moderate, since that is what the drug is approved for.
  • For psoriasis or psoriatic arthritis: tried an older treatment firstPlans often want proof that an older treatment, such as methotrexate, did not work or was not safe for you, unless you already used a similar advanced drug.
  • For Crohn's or colitis: liver blood tests firstThe FDA label says to check liver enzymes and bilirubin before starting Skyrizi for Crohn's disease or ulcerative colitis.
  • For renewals: notes showing the drug helpsTo keep coverage, your doctor must show the drug is working for you.

Based on published policies from several large commercial insurers and the FDA label (see Sources). Medicare, Medicaid and other plans may use different rules. Your plan's rules may differ.

Why was Skyrizi denied, and what can I do?

  1. Decode your denial letter: Ellen explains the reason in plain words.
  2. Check your denial type and your rights (Medicare or Medicaid if that's your coverage).
  3. Build your appeal, with the step-by-step appeal guide.
Decode my Skyrizi denial

How can I lower the cost of Skyrizi?

If you have Medicare or Medicaid, check each program's terms before you apply.

How does Skyrizi compare?

Safety information

From FDA-approved prescribing information for Skyrizi (IL-23 Inhibitor).

Do not use if

  • Clinically significant hypersensitivity to risankizumab

Key warnings

  • Evaluate for TB before starting
  • May increase risk of infections

This is not a complete list. See the full Skyrizi prescribing information or ask your pharmacist for complete safety information.

For clinicians: Skyrizi prior authorization card (printable).

Sources: FDA prescribing information for Skyrizi (DailyMed) and these insurers' published policies: Aetna (Last Review 10/14/2026), Cigna (IV for Crohn's and UC) (Effective Date 08/01/2026), UnitedHealthcare (Effective Date 10/1/2026). Checked 2026-11-10. Sources reviewed Nov 10, 2026.

Not medical advice. This page is for educational and informational purposes only. It does not replace professional medical judgment. Always consult your prescribing physician or pharmacist before starting, stopping, or changing any medication. Ellen does not provide medical advice, diagnose conditions, or recommend treatments. Coverage rules vary by plan and change often; confirm with your plan's current policy.